Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lupin designs new CaSR agonists

March 19, 2014

Lilly discloses new homodimeric proteins

March 19, 2014

RIPK3, a potential drug target for Gaucher's disease

March 19, 2014

uniQure and Chiesi Farmaceutici report 6-year follow-up data for Glybera

March 18, 2014

Theracos reports data from phase II study of THR-1442 in type 2 diabetes

March 18, 2014

Amgen reports topline results from the phase III TESLA trial

March 18, 2014

Merck & Co. designs new agents for diabetes and other disorders

March 18, 2014

A first-in-class melanocortin MC4 receptor agonist for the treatment of sexual dysfunction

March 18, 2014

Islet Sciences to acquire BHV Pharma, remogliflozin etabonate

March 17, 2014

BioMarin Pharmaceutical designs new agent for mucopolysaccharidosis type IIIB

March 17, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...